Shandong Keyuan Pharmaceutical: Announcement regarding the wholly-owned subsidiary applying for project loans from banks with mortgage guarantee provided by the company.
Shandong Keyuan Pharmaceutical: Summary Table of Non-Operating Funds Used and Other Related Fund Transactions for the First Half of 2024.
Shandong Keyuan Pharmaceutical: Announcement on the resignation of the general manager and the appointment of the general manager
Keyuan Pharmaceutical: Progress announcement on the use of some idle funds raised and own funds for cash management, maturity redemption, and continued cash management
Keyuan Pharmaceutical: Announcement on the conclusion of the initial public offering of shares and the cancellation of the special account
Keyuan Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Keyuan Pharmaceutical: Announcement on amending the company's articles of association
Keyuan Pharmaceutical: 2023 Financial Results Report
Keyuan Pharmaceutical: Announcement on Establishing a Special Fund Raising Account and Signing a Tripartite Supervision Agreement
Keyuan Pharmaceutical: 2023 Internal Control Self-Evaluation Report
Keyuan Pharmaceutical: Articles of Association of Shandong Keyuan Pharmaceutical Co., Ltd. (revised in March 2024)
Keyuan Pharmaceutical: Announcement on revising the company's relevant governance system
Keyuan Pharmaceutical: Announcement on changes in supervisors
Keyuan Pharmaceutical: Notice on requesting the shareholders' meeting to authorize the board of directors to handle matters relating to issuing shares to specific targets through simplified procedures
Keyuan Pharmaceutical: 2023 Annual Financial Report
Keyuan Pharmaceutical: Announcement on the 2024 Remuneration Plan for Directors, Supervisors and Senior Managers
Keyuan Pharmaceutical: Notice on Using Some Idle Funds Raised and Own Funds for Cash Management
Keyuan Pharmaceutical: Notice on Convening the 2023 Annual General Meeting of Shareholders
Keyuan Pharmaceutical: Report on the Board Audit Committee\'s evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Keyuan Pharmaceutical: Summary table on the use of non-operating capital and other related capital transactions in 2023
No Data